Regeneron Pharmaceuticals (REGN) News Today $571.06 +16.88 (+3.05%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Goldman Sachs Sticks to Its Buy Rating for Regeneron (REGN)April 14 at 9:04 PM | markets.businessinsider.comReflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)April 14 at 11:03 AM | msn.comDistillate Capital Partners LLC Buys Shares of 32,141 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Distillate Capital Partners LLC bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 32,141 shares of the biopharmaceutical compaApril 14 at 7:37 AM | marketbeat.comRegeneron Pharmaceuticals (REGN) -- Navigating Market Volatility with Innovative Therapies | ...April 13 at 6:19 PM | gurufocus.comRegeneron Pharmaceuticals (REGN) -- Navigating Market Volatility with Innovative Therapies | ...April 13 at 5:55 PM | gurufocus.com679 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Coign Capital Advisors LLCCoign Capital Advisors LLC acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 679 shares of the biopharmaceuticalApril 13 at 8:01 AM | marketbeat.comHeritage Trust Co Purchases Shares of 2,411 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Heritage Trust Co purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 2,411 shares of the biopharmaceutical company's stock, valued at approximatelApril 13 at 7:43 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by F M Investments LLCF M Investments LLC raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,003 shares of the bioApril 13 at 6:16 AM | marketbeat.comTreasurer of the State of North Carolina Sells 490 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Treasurer of the State of North Carolina lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 58,123 shares of the bioApril 12 at 8:48 AM | marketbeat.comFIL Ltd Has $75.54 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)FIL Ltd raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 5.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,041 shares of the biopharmaceutical company'April 12 at 6:05 AM | marketbeat.comCerity Partners LLC Raises Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Cerity Partners LLC boosted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 3.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,060 shares of the biopharmaceutical company's stock aftApril 12 at 5:48 AM | marketbeat.comEnvestnet Asset Management Inc. Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Envestnet Asset Management Inc. lifted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 12.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,138 shares of the biApril 12 at 5:15 AM | marketbeat.comThis Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.April 11, 2025 | barrons.comCenterBook Partners LP Sells 7,784 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)CenterBook Partners LP cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 32.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,984 shares of the biopharmaceutical comApril 11, 2025 | marketbeat.comMartingale Asset Management L P Has $14.40 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Martingale Asset Management L P reduced its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 6.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,208 shares of the biopharmaApril 11, 2025 | marketbeat.comAPG Asset Management N.V. Has $56.24 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)APG Asset Management N.V. lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 275.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 81,755 shares of the biopharmaceutical company's stoApril 11, 2025 | marketbeat.comBank of Nova Scotia Has $64.23 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Bank of Nova Scotia lowered its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 8.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 90,162 shares of the biopharmaceutical company's stock after selliApril 11, 2025 | marketbeat.comBank of Montreal Can Trims Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Bank of Montreal Can decreased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 18.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 153,267 shares of the biopharmaceutical cApril 11, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Federated Hermes Inc.Federated Hermes Inc. boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 535.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,963 shares of the biopharmaceutical company's stock after acquiring an additionApril 11, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (REGN) Stock ForecastsApril 11, 2025 | finance.yahoo.comRegeneron price target lowered to $940 from $950 at GuggenheimApril 10, 2025 | markets.businessinsider.comRegeneron Pharmaceuticals (NASDAQ:REGN) Hits New 1-Year Low - Time to Sell?Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 1-Year Low - What's Next?April 10, 2025 | marketbeat.comRenaissance Technologies LLC Has $176.48 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Renaissance Technologies LLC increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 17.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 247,743 shares of the biopharmaceutical compaApril 10, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Legal & General Group PlcLegal & General Group Plc decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 18.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 777,477 shares of the biopharmaceuticApril 10, 2025 | marketbeat.comInvesco Ltd. Sells 296,924 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Invesco Ltd. lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 25.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 864,249 shares of the biopharmaceutical company's stock after sellingApril 10, 2025 | marketbeat.comPeapack Gladstone Financial Corp Grows Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Peapack Gladstone Financial Corp grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 26.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,839 shares of the biopharmaceuticalApril 10, 2025 | marketbeat.comWells Fargo & Company MN Sells 21,533 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Wells Fargo & Company MN trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 12.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 152,508 shares of the biopharmaceutical company's sApril 10, 2025 | marketbeat.comAutos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackApril 10, 2025 | cnbc.comRegeneron price target lowered to $1,081 from $1,150 at Morgan StanleyApril 9, 2025 | markets.businessinsider.comMorgan Stanley Sticks to Its Buy Rating for Regeneron (REGN)April 9, 2025 | markets.businessinsider.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comPharma Stocks Slide Further After Trump Reiterates Tariff Threats on DrugsApril 9, 2025 | wsj.comPharma Stocks Slide Further After Trump Reiterates Tariff Threats on DrugsApril 9, 2025 | wsj.comPharmaceutical stocks fall as Trump doubles down on tariffs threatApril 9, 2025 | cnbc.comPharmaceutical stocks fall as Trump doubles down on tariffs threatApril 9, 2025 | cnbc.comADAR1 Capital Management LLC Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)ADAR1 Capital Management LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 56.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,361 shares of the biopharmaceutical company's stock aftApril 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Cuts Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Massachusetts Financial Services Co. MA decreased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 97.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,234 shares of the biopharmaceutical company's stockApril 9, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Decreased by Fmr LLCFmr LLC trimmed its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 20.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,199,579 shares of the biopharmaceutical companyApril 8, 2025 | marketbeat.comIlmarinen Mutual Pension Insurance Co Has $8.12 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Ilmarinen Mutual Pension Insurance Co raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 42.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,400 shares of the biophaApril 8, 2025 | marketbeat.comRussell Investments Group Ltd. Has $97.69 Million Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Russell Investments Group Ltd. boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 137,208 shares of the biopharmaceutical company's stoApril 8, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Lifted by Aviva PLCAviva PLC boosted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 10.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,140 shares of the biopharmaceutical company's stock after purchaApril 8, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Prudential PLCPrudential PLC cut its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 27.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 3,471 shares of the biopharmaceutical company's stock after selling 1,322 sharesApril 8, 2025 | marketbeat.comResona Asset Management Co. Ltd. Invests $26.51 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Resona Asset Management Co. Ltd. acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 37,211 shares of the bioApril 8, 2025 | marketbeat.com4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall StreetApril 7, 2025 | fool.comGrantham Mayo Van Otterloo & Co. LLC Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Grantham Mayo Van Otterloo & Co. LLC boosted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 21.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 62,979 shares of the biopharmaceutical company's stocApril 7, 2025 | marketbeat.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 43,457 shares of the biophApril 7, 2025 | marketbeat.com6,900 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Pamalican Asset Management LtdPamalican Asset Management Ltd acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 6,900 shares of the biopharmaceutical compApril 6, 2025 | marketbeat.comOrion Investment Co Has $21.29 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)Orion Investment Co grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,886 shares of the biopharmaceutApril 6, 2025 | marketbeat.comRegeneron: Market Overlooks A Resilient Franchise And Robust Free Cash FlowApril 6, 2025 | seekingalpha.com Remove Ads Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Media Mentions By Week REGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼1.050.80▲Average Medical News Sentiment REGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼4627▲REGN Articles Average Week Remove Ads Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News BioMarin Pharmaceutical News Exelixis News Neurocrine Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
